Pfizer to buy cancer drug maker Seagen for $43 billion

Pfizer to buy cancer drug maker Seagen for $43 billion

Pfizer struck a roughly $43 billion deal for Seagen to bulk up its cancer treatment portfolio.


Share:

Comments

Comentarios de Facebook